Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “neurofibromatosis1 (NF1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Not applicableStudy completedNCT04212351
What this trial is testing

Frameshift Peptides of Children With NF1

Who this might be right for
Neurofibromatosis Type 1
Children's National Research Institute 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06620354
What this trial is testing

Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule

Who this might be right for
Neurofibromatosis 1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 33
Large-scale testing (Phase 3)UnknownNCT00921037
What this trial is testing

First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas

Who this might be right for
Cutaneous Neurofibromas
Medical University of Vienna 12
Not applicableLooking for participantsNCT07233408
What this trial is testing

Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy

Who this might be right for
Neurofibromatosis 1
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02964884
What this trial is testing

Interventions for Reading Disabilities in NF1

Who this might be right for
Neurofibromatosis Type 1Learning DisabilityReading Disability+1 more
Vanderbilt University 120
Not applicableStudy completedNCT01851135
What this trial is testing

Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis Type 1
Nantes University Hospital 286
Testing effectiveness (Phase 2)Active Not RecruitingNCT03190915
What this trial is testing

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

Who this might be right for
Juvenile Myelomonocytic LeukemiaNeurofibromatosis Type 1
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT04481035
What this trial is testing

Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
Children's Hospital Medical Center, Cincinnati 5
Not applicableStudy completedNCT01410006
What this trial is testing

Neurofibromatosis Type 1 Patient Registry

Who this might be right for
Neurofibromatosis Type 1
Washington University School of Medicine 2,391
Not applicableUnknownNCT01218152
What this trial is testing

Microarray CGH Analysis of Circulating Tumoral Plasma DNA in NF1 Patients With MPNSTs

Who this might be right for
Neurofibromatosis Type 1
KU Leuven 20
Testing effectiveness (Phase 2)WithdrawnNCT03109301
What this trial is testing

Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Neoplasms, Nerve TissueNeurofibromatosis 1Heredodegenerative Disorders, Nervous System+1 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT05361811
What this trial is testing

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Who this might be right for
Neurofibromatosis 1Noonan SyndromeLegius Syndrome+2 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT03090971
What this trial is testing

Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1

Who this might be right for
Neurofibromatosis 1Cutaneous Neurofibroma
Fundação Educacional Serra dos Órgãos 7
Not applicableLooking for participantsNCT04395495
What this trial is testing

RASopathy Biorepository

Who this might be right for
RAS MutationNeurofibromatosis 1Noonan Syndrome+11 more
Children's Hospital Medical Center, Cincinnati 1,000
Large-scale testing (Phase 3)Study completedNCT02471339
What this trial is testing

Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain

Who this might be right for
Neurofibromatosis Type 1Plexiform Neurofibromas
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT00314119
What this trial is testing

Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis Type 1Neurofibroma
National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT00865644
What this trial is testing

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

Who this might be right for
Neurofibromatosis Type 1Cutaneous Neurofibromas
Massachusetts General Hospital 11
Not applicableUnknownNCT01650142
What this trial is testing

Modifying Genes in Neurofibromatosis 1

Who this might be right for
Neurofibromatosis 1
Assistance Publique - Hôpitaux de Paris 450